Summary Stage 2018: Corpus Carcinoma and Carcinosarcoma
Summary Stage 2018
Notes
**Corpus Carcinoma and Carcinosarcoma** 8000-8700, 8720-8790, 8950, 8980, 9700-9701 C540-C543, C548-C549, C559 C540 Isthmus uteri C541 Endometrium C542 Myometrium C543 Fundus uteri C548 Overlapping lesion of corpus uteri C549 Corpus uteri C559 Uterus, NOS **Note 1:** The following sources were used in the development of this chapter * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 53 *Corpus Uteri-Carcinoma and Carcinosarcoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following schemas for the listed histologies * 8710-8714, 8800-8941, 8951-8975, 8981-9137, 9141-9582: *Corpus Sarcoma* * 9140: *Kaposi Sarcoma*NAACCR Item
NAACCR #764| SS2018 | Description |
|---|---|
| 0 | In situ, intraepithelial, noninvasive, preinvasive |
| 1 | Localized only (localized, NOS) - FIGO Stage IA + Invasion of inner half of myometrium - FIGO Stage IB + Invasion of outer half of myometrium - FIGO Stage I [NOS] + Confined to uterus, NOS + Invasion of myometrium, NOS + Invasive cancer confined to corpus uteri |
| 2 | Regional by direct extension only - FIGO Stage II + Cervix uteri, NOS + Cervical stromal invasion + Endocervical glandular involvement + Tumor invading the stromal connective tissue of the cervix but not extending beyond the uterus - FIGO Stage IIIA + Adnexa (direct extension or metastasis) + Fallopian tube(s) + Ovary(ies) + Serosa, NOS + Tunica serosa (visceral peritoneum of corpus, serosa covering the corpus) + Tunica serosa of corpus - FIGO Stage IIIB + Bladder, NOS (excluding mucosa) + Described clinically as "frozen pelvis", NOS + Ligaments (broad, round, uterosacral) + Parametrium, NOS + Parietal serosa of pelvic wall + Pelvic wall(s) + Peritoneal cytology positive for malignant cells + Rectal wall + Rectum, NOS excluding mucosa + Ureter + Vagina (direct extension or metastasis) + Visceral peritoneum of pelvic organs excluding serosa of corpus + Vulva - FIGO Stage III [NOS] |
| 3 | Regional lymph node(s) involved only - Aortic (lateral [lumbar], Periaortic, NOS) - Iliac (external, internal [hypogastric], NOS) - Lateral (laterosacral) - Middle (promontorial) (Gerota’s node) - Obturator - Para-aortic - Paracervical - Parametrial - Pelvic, NOS - Presacral - Sacral - Uterosacral - Regional lymph node(s), NOS + Lymph node(s), NOS |
| 4 | Regional by BOTH direct extension AND regional lymph node(s) involved - Codes (2) + (3) |
| 7 | Distant site(s)/lymph node(s) involved - Distant site(s) (including further contiguous extension) + FIGO Stage IVA * Abdominal serosa (visceral or parietal peritoneum of abdomen) * Bladder mucosa (excluding bullous edema) * Bowel mucosa * Cul de sac (rectouterine pouch or Pouch of Douglas) * Sigmoid colon * Small intestine + FIGO Stage IVB * Bone * Intraperitoneal disease * Liver * Lung + FIGO Stage IV [NOS] - Distant lymph node(s), NOS + Deep inguinal, NOS * Node of Cloquet or Rosenmuller (highest deep inguinal) + Inguinal, NOS + Superficial inguinal (femoral) - Distant metastasis, NOS + Carcinomatosis + Distant metastasis WITH or WITHOUT distant lymph node(s) |
| 9 | Unknown if extension or metastasis |